Otsuka Holdings Co., Ltd.: Colorectal Neoplasms trials

The registry lists 17 Colorectal Neoplasms studies with Otsuka Holdings Co., Ltd. as lead sponsor. 1 are open to participants now and 6 have results posted.

Phase 1 2Phase 2 9Phase 3 5No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• AB122 Platform StudyRecruitingNCT04999761Phase 1
• Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer PatientsCompletedNCT04737187Phase 3Results posted
• A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRCCompletedNCT02860546Phase 2Results posted
• Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in AsiaCompletedNCT01955837Phase 3Results posted
• A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal CancerCompletedNCT01801930Phase 1Results posted
• Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard ChemotherapiesCompletedNCT01607957Phase 3Results posted
• Phase II Study of TAS-109 to Treat Advanced Colorectal CancerTerminatedNCT00824161Phase 2Results posted
• The CHOICE RegistryTerminatedNCT03148093
• Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal CancerApproved for marketingNCT02286492
• Study of S-1 Plus LV for Untreated Metastatic Colorectal CancerCompletedNCT00891332Phase 2
• Randomized Phase II Study of SOL for Untreated Metastatic Colorectal CancerCompletedNCT00721916Phase 2
• Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569790Phase 2
• Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)CompletedNCT00569699Phase 2
• Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569335Phase 2
• Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal CancerCompletedNCT00284258Phase 2/3
• A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)CompletedNCT00152230Phase 3
• Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal CancerStatus unknownNCT00005877Phase 2